Related Experiment Video
Updated: Aug 2, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
The first DRG: lessons from the end stage renal disease program for the prospective payment system
Abstract:
When Medicare implemented the diagnosis related group (DRG) method of reimbursement for hospitals in 1983, it already had a decade of experience using a prospective payment arrangement for its end stage renal disease (ESRD) program. We reviewed this experience to determine the lessons for Medicare's reimbursement of hospital services. The use of a fixed price for renal dialysis encouraged the introduction of cost-saving techniques. Failure to reduce the price for dialysis in keeping with the cost reductions, however, prevented the government from realizing the full benefits of prospective payment. In addition, there were important changes in medical practice that had independent effects on the program. Similar influences are likely to shape the impact of prospective payment on hospital behavior.
Insights
Medicare's early prospective payment system for end-stage renal disease (ESRD) encouraged cost savings but failed to fully benefit the government due to unadjusted prices. Lessons learned from ESRD reimbursement inform hospital payment strategies.
Area of Science:
- Health economics
- Healthcare policy
- Medical reimbursement systems
Background:
- Medicare implemented Diagnosis Related Groups (DRG) for hospital reimbursement in 1983.
- A decade of prior experience with prospective payment existed for the End-Stage Renal Disease (ESRD) program.
Purpose of the Study:
- To review Medicare's ESRD prospective payment experience.
- To identify lessons applicable to Medicare's hospital services reimbursement.
Main Methods:
- Review of Medicare's historical reimbursement data and program outcomes for ESRD.
- Analysis of the impact of fixed-price reimbursement on provider behavior and cost-saving initiatives.
Main Results:
- Prospective payment for renal dialysis incentivized cost-saving techniques by providers.
- Failure to adjust dialysis prices in line with cost reductions limited government savings.
- Independent changes in medical practice also influenced program outcomes.
Conclusions:
- Prospective payment systems can drive efficiency but require price adjustments to maximize benefits.
- Lessons from ESRD reimbursement are relevant for understanding the impact of DRG-based hospital payments.
- External factors, such as medical practice evolution, significantly affect prospective payment system outcomes.
Related Concept Videos
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Kidney Transplant I: Introduction
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care

